| Abstract: | RTx is currently the best treatment for children with ESRD. This study retrospectively analyzed the outcomes of growth after RTx using the pediatric‐to‐pediatric allocation strategy and some factors that may affect it. From March 2012 to August 2016, 8 en bloc and 38 single pediatric RTxs were performed at our center using organs from small pediatric deceased donors (weight < 15 kg). Growth before and after RTx was analyzed according to the height‐for‐age z‐score at RTx, the 3‐year follow‐up, and adulthood and compared between the procedures. The chi‐square test and multiple linear regression analysis were used for statistical analyses. Overall, 79.2% of children were diagnosed with chronic nephritis before RTx; 14.6% of cases were due to congenital urinary tract malformation, and 6.3% of cases were due to unknown causes. All grafts and patients survived postoperatively. The mean estimated GFRs were 92.7 ± 28.6 mL/min/1.73 m2, 100.9 ± 32.3 mL/min/1.73 m2, and 110.1 ± 34.8 mL/min/1.73 m2 at 1, 2, and 3 years’ postoperatively, respectively. The children's postoperative growth and development, particularly during the first year postoperatively, improved but were negatively correlated with age and the height‐for‐age z‐score before RTx. The growth of children after RTx was moderate and accelerated during prepubescence. The rate of post‐RTx growth during the first year postoperatively was unrelated to the recipient's sex or duration of dialysis (P > 0.05) but was negatively correlated with age at RTx (r = ?0.349, P = 0.043). Future studies on the long‐term outcomes are still needed. |
